These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31654490)

  • 1. HSD10 mitochondrial disease: p.Leu122Val variant, mild clinical phenotype, and founder effect in French-Canadian patients from Quebec.
    Waters PJ; Lace B; Buhas D; Gravel S; Cyr D; Boucher RM; Bernard G; Lévesque S; Maranda B
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1000. PubMed ID: 31654490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSD10 disease: clinical consequences of mutations in the HSD17B10 gene.
    Zschocke J
    J Inherit Metab Dis; 2012 Jan; 35(1):81-9. PubMed ID: 22127393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular analysis of 6 Chinese patients with isoleucine metabolism defects: identification of 3 novel mutations in the HSD17B10 and ACAT1 gene.
    Su L; Li X; Lin R; Sheng H; Feng Z; Liu L
    Metab Brain Dis; 2017 Dec; 32(6):2063-2071. PubMed ID: 28875337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSD10 disease in a female: A case report and review of literature.
    Upadia J; Walano N; Noh GS; Liu J; Li Y; Deputy S; Elliott LT; Wong J; Lee JA; Caylor RC; Andersson HC
    JIMD Rep; 2021 Nov; 62(1):35-43. PubMed ID: 34765396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5-methylcytosine hotspot responsible for the prevalent HSD17B10 mutation.
    Yang SY; Dobkin C; He XY; Philipp M; Brown WT
    Gene; 2013 Feb; 515(2):380-4. PubMed ID: 23266819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel patient missense mutations in the HSD17B10 gene affect dehydrogenase and mitochondrial tRNA modification functions of the encoded protein.
    Oerum S; Roovers M; Leichsenring M; Acquaviva-Bourdain C; Beermann F; Gemperle-Britschgi C; Fouilhoux A; Korwitz-Reichelt A; Bailey HJ; Droogmans L; Oppermann U; Sass JO; Yue WW
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3294-3302. PubMed ID: 28888424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in the HSD17B10 gene of a 10-year-old boy with refractory epilepsy, choreoathetosis and learning disability.
    Seaver LH; He XY; Abe K; Cowan T; Enns GM; Sweetman L; Philipp M; Lee S; Malik M; Yang SY
    PLoS One; 2011; 6(11):e27348. PubMed ID: 22132097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene.
    Ofman R; Ruiter JP; Feenstra M; Duran M; Poll-The BT; Zschocke J; Ensenauer R; Lehnert W; Sass JO; Sperl W; Wanders RJ
    Am J Hum Genet; 2003 May; 72(5):1300-7. PubMed ID: 12696021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese Male Siblings with 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency (HSD10 Disease) Without Neurological Regression.
    Akagawa S; Fukao T; Akagawa Y; Sasai H; Kohdera U; Kino M; Shigematsu Y; Aoyama Y; Kaneko K
    JIMD Rep; 2017; 32():81-85. PubMed ID: 27306202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first case in Asia of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (HSD10 disease) with atypical presentation.
    Fukao T; Akiba K; Goto M; Kuwayama N; Morita M; Hori T; Aoyama Y; Venkatesan R; Wierenga R; Moriyama Y; Hashimoto T; Usuda N; Murayama K; Ohtake A; Hasegawa Y; Shigematsu Y; Hasegawa Y
    J Hum Genet; 2014 Nov; 59(11):609-14. PubMed ID: 25231369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-inactivation of HSD17B10 revealed by cDNA analysis in two female patients with 17β-hydroxysteroid dehydrogenase 10 deficiency.
    García-Villoria J; Gort L; Madrigal I; Fons C; Fernández C; Navarro-Sastre A; Milà M; Briones P; García-Cazorla A; Campistol J; Ribes A
    Eur J Hum Genet; 2010 Dec; 18(12):1353-5. PubMed ID: 20664630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation or knock-down of 17β-hydroxysteroid dehydrogenase type 10 cause loss of MRPP1 and impaired processing of mitochondrial heavy strand transcripts.
    Deutschmann AJ; Amberger A; Zavadil C; Steinbeisser H; Mayr JA; Feichtinger RG; Oerum S; Yue WW; Zschocke J
    Hum Mol Genet; 2014 Jul; 23(13):3618-28. PubMed ID: 24549042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel HSD17B10 mutation impairing the activities of the mitochondrial RNase P complex causes X-linked intractable epilepsy and neurodevelopmental regression.
    Falk MJ; Gai X; Shigematsu M; Vilardo E; Takase R; McCormick E; Christian T; Place E; Pierce EA; Consugar M; Gamper HB; Rossmanith W; Hou YM
    RNA Biol; 2016 May; 13(5):477-85. PubMed ID: 26950678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infantile Neurodegeneration Results from Mutants of 17β-Hydroxysteroid Dehydrogenase Type 10 Rather Than Aβ-Binding Alcohol Dehydrogenase.
    He XY; Dobkin C; Brown WT; Yang SY
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxysteroid (17β) dehydrogenase X in human health and disease.
    Yang SY; He XY; Miller D
    Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deacetylation of HSD17B10 by SIRT3 regulates cell growth and cell resistance under oxidative and starvation stresses.
    Liu L; Chen S; Yu M; Ge C; Ren M; Liu B; Yang X; Christian TW; Hou YM; Zou J; Zhu WG; Luo J
    Cell Death Dis; 2020 Jul; 11(7):563. PubMed ID: 32703935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental retardation linked to mutations in the HSD17B10 gene interfering with neurosteroid and isoleucine metabolism.
    Yang SY; He XY; Olpin SE; Sutton VR; McMenamin J; Philipp M; Denman RB; Malik M
    Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14820-4. PubMed ID: 19706438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spastic diplegia and periventricular white matter abnormalities in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism: differential diagnosis with hypoxic-ischemic brain diseases.
    Poll-The BT; Wanders RJ; Ruiter JP; Ofman R; Majoie CB; Barth PG; Duran M
    Mol Genet Metab; 2004 Apr; 81(4):295-9. PubMed ID: 15059617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular insights into HSD10 disease: impact of SDR5C1 mutations on the human mitochondrial RNase P complex.
    Vilardo E; Rossmanith W
    Nucleic Acids Res; 2015 May; 43(10):5112-9. PubMed ID: 25925575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis and genetic diagnosis of three children with Isoleucine metabolic disorders due to variants of HSD17B10 and ACAT1 genes].
    Ji W; Tian G; Zhang X; Wang Y; Yang Y; Zhou Z; Guo J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 May; 41(5):540-545. PubMed ID: 38684297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.